More Is Not Better When It Comes to Treating Rectal Cancer With Multimodal Chemoradiation Beyond the Standard Radiation Dose of 5040 cGy-论文-万方医学网

More Is Not Better When It Comes to Treating Rectal Cancer With Multimodal Chemoradiation Beyond the Standard Radiation Dose of 5040 cGy

导出原文传递

翻译打印收藏纠错

作者： Abraham, Aswin George ^[1] ; Joseph, Kurian ^[2] ; Ghosh, Sunita ^[3] ; Yun, Jihyun ; Warkentin, Brad J. ; Thai, JoAnn J. ; Cheung, Winson Y. ; Xu, Yuan ; Nijjar, Tirath S. ; Severin, Diane M. ; Tankel, Keith ; Fairchild, Alysa M. ; Usmani, Nawaid

作者单位： Div Radiat Oncol,Cross Canc Inst ^[1] Dept Oncol,Univ Alberta ^[2] Dept Oncol,Univ Calgary ^[3]

关键词 Dose escalation Neoadjuvant chemoradiation Pathological response Rectal cancer Treatment response PATHOLOGICAL COMPLETE RESPONSE POSTOPERATIVE CHEMORADIOTHERAPY PREOPERATIVE RADIATION PERINEURAL INVASION RANDOMIZED-TRIAL FOLLOW-UP ESCALATION ADENOCARCINOMA CHEMOTHERAPY RADIOTHERAPY

发布时间 2022-07-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

More Is Not Better When It Comes to Treating Rectal Cancer With Multimodal Chemoradiation Beyond the Standard Radiation Dose of 5040 cGy

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

More Is Not Better When It Comes to Treating Rectal Cancer With Multimodal Chemoradiation Beyond the Standard Radiation Dose of 5040 cGy

相似文献

相关期刊

检索历史清除